CANCER DURING THE PANDEMIC OF CORONAVIRUS INFECTION COVID-19

Abstract

The new coronavirus, also known as SARS-Cov-2 or COVID-19, became a global threat and a major healthcare problem in2020. The onset of this disease had an impact on the management of cancer patients. According to some Chinese researches, cancer patients are more vulnerable to COVID-19 complications. This observation has led many oncologists to change their daily cancer treatment practices without solid evidence or recommendations. In addition, the manifestations of COVID-19, as well as its diagnosis, are specific to this particular population. Consideration of the potential risk and beneficial effects for specific antitumor therapy in a population of cancer patients should be personified. Postponement of elective surgery or adjuvant chemotherapy for cancer patients with a low risk of progression should be considered in each case. Minimizing outpatient visits can help reduce the number of people infected and prevent the spread of the dangerous virus. Telemedicine can be used to support patients in order to minimize the number of visits. This article will discuss the potential problems associated with the treatment of cancer patients during a pandemic of COVID-19 infection, with the proposals of some practical approaches of oncologists in China, Italy and France.